“Interleukin-enhancer binding factor 2 expression associates with chemotherapy response in triple-negative breast cancer
Document Type
Presentation
Publication Date
12-1-2019
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
Presentation
12-1-2019
Cancer
Oncology
Comments
” San Antonio Breast Cancer Symposium, December 2019 San Antonio, TX, USA; P6-03-11